Bunge Operating Cash Flow decreased by 140.2% to -$541.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 89.8%, from -$285.00M to -$541.00M. Over 3 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a -33.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$723.50M | -$723.50M | -$723.50M | -$1.39B | -$1.39B | -$1.39B | -$1.39B | $931.00M | $1.39B | $1.45B | $994.00M | -$1.47B | $1.33B | $1.05B | -$285.00M | -$1.07B | $854.00M | $1.35B | -$541.00M |
| QoQ Change | — | +0.0% | +0.0% | -91.7% | +0.0% | +0.0% | +0.0% | +167.1% | +49.1% | +4.3% | -31.4% | -248.3% | +190.0% | -20.6% | -127.1% | -276.1% | +179.7% | +57.7% | -140.2% |
| YoY Change | — | — | — | — | -91.7% | -91.7% | -91.7% | +167.1% | +200.1% | +204.4% | +6.8% | — | -4.4% | -27.3% | -128.7% | +27.3% | -35.6% | +27.9% | -89.8% |